Vivos Therapeutics, Inc.VVOSNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank71
3Y CAGR-10.1%
5Y CAGR+6.3%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
-10.1%/yr
vs +34.7%/yr prior
5Y CAGR
+6.3%/yr
Recent deceleration
Acceleration
-44.8pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
1.4x
Solid growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $24.96M | +27.3% |
| 2024 | $19.61M | -21.1% |
| 2023 | $24.85M | -27.7% |
| 2022 | $34.38M | +9.7% |
| 2021 | $31.34M | +70.3% |
| 2020 | $18.40M | -0.4% |
| 2019 | $18.48M | +77.1% |
| 2018 | $10.44M | - |